Filing Details
- Accession Number:
- 0001415889-23-015909
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-05 21:08:03
- Reporting Period:
- 2023-11-30
- Accepted Time:
- 2023-12-05 21:08:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 855654 | Immunogen Inc. | IMGN | Pharmaceutical Preparations (2834) | 042726691 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1814150 | Ann Stacy Coen | C/O Immunogen, Inc. 830 Winter Street Waltham MA 02451 | Svp & Chief Business Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-11-30 | 3,826 | $29.20 | 33,140 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Effected pursuant to a trading plan adopted on August 10, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
Billionaire Hedge Funds
